RegMed Daily Dialogue, 8/31/11, goodbye to August, worried about the historically cruel September
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The US FDA designated PSTI’s PLX cells orphan status for the treatment of thromboangiitis obliterans (Buerger’s disease). Read more…
Expanding Cancer Programs Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The 6 W’s: Who, what, where, when, why and what of it… Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.